Advertisement

My profile in epilepsy

Published:December 28, 2016DOI:https://doi.org/10.1016/j.yebeh.2016.10.038
      In attempting to sketch my career in epilepsy, I find it is difficult to separate the epilepsy-related portions from other medically- and neurologically-related aspects including pharmacology, and non-medically related events. (See Fig. 1, Fig. 2.)
      Fig. 1
      Fig. 1MBBS graduation photo, from 1960, Melbourne University.
      Fig. 2
      Fig. 2Picture taken at the time of my Festschrift, at my 80th birthday, late last year.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eadie M.J.
        • Vajda F.J.E.
        Handbook of experimental pharmacology.
        in: Antiepileptic drugs pharmacology and therapeutics. vol. 138. Springer-Verlag, Berlin, Heidelberg, New York1999
        • Eadie M.J.
        • Vajda F.J.E.
        Antiepileptic drugs and pregnancy.
        in: Guide for prescribers. Springer, Adis Switzerland2015
        • Vajda F.J.E.
        • Martin T.J.
        • Melick R.A.
        Destruction of bovine parathyroid labelled with 1311 by rat kidney tissues.
        Endocrinology. 1969; 84: 162-164
        • Collaborative Group
        Phenytoin after recovery from myocardial infarction.
        Lancet. 1970; 2: 295-296
        • Vajda F.J.E.
        Value of plasma phenytoin levels in the treatment of epilepsy.
        Med J Aust. 1970; 2: 1074-1076
        • Vajda F.J.E.
        • Prineas R.J.
        • Lovell R.R.H.
        Interaction between phenytoin and the benzodiazepines.
        Brit Med J. 1971; 1: 346-347
        • Vajda F.J.E.
        • Lovell R.R.H.
        • Prineas R.J.
        Epileptics on phenytoin.
        Brit Med J. 1972; 2: 295-296
        • Vajda F.J.E.
        • Williams F.M.
        • Breckenridge A.M.
        • Davidson S.
        • Falconer M.A.
        Human brain, cerebrospinal fluid and plasma concentrations of diphenylhydantion and phenobarbital.
        Clin Pharm Therap. 1974; 15: 597-603
        • Vajda F.J.E.
        The measurement of plasma levels of antiepileptic drugs.
        Aust Prescriber. 1975; 1: 6-7
        • Vajda F.J.E.
        • Merory J.
        • Bladin P.F.
        Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes.
        Proc Aust Assoc Neurol. 1975; 12: 61-64
        • Drummer O.
        • Morris P.
        • Vajda F.J.E.
        Plasma carbamazepine determinations: a simple gas chromatographic method.
        Clin Exp Pharmacol Physiol. 1976; 3: 497-501
        • LeQuesne P.
        • Goldberg V.
        • Vajda F.J.E.
        Acute conduction velocity changes in guinea-pigs after administration of diphenylhydantoin.
        J Neurol Neurosurg Psych. 1976; 10: 95-100
        • Williams F.M.
        • Vajda F.J.E.
        • Breckenridge A.
        • Davidson S.
        • Flaconer M.A.
        Relationship between brain, CSF and plasma concentrations of anticonvulsant drugs in man.
        in: Harris M. The natural history of management of epilepsy. Proceedings of Hans Berger centenary symposium. Raven Press, Edinburgh1974: 381-401
        • Vajda F.J.E.
        • Morris P.
        • Drummer O.
        • Bladin P.F.
        Studies on sodium valproate - a new anticonvulsant.
        in: Legg Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. MCS Consultants, Tunbridge Wells1976: 92-100
        • Vajda F.J.E.
        Valproic acid in the treatment of status epilepticus.
        in: Delgado Escueta A.V. Wasterlain C.G. Trieman D.M. Porter R.J. Status epilepticus, advances in neurology. Vol. 34. Raven Press, New York1983: 520-529
        • Vajda F.J.E.
        Brain and peripheral concentration of anticonvulsants.
        in: Doyle A.E. Mendelsohn F.A.O. Membranes and receptors. Elsevier, 1984: 237-244
        • Vajda F.J.E.
        Anticonvulsant drugs: an overview. Chapter 8, In: antimanics, anticonvulsants and other drugs in psychiatry.
        in: Drugs in psychiatry. vol 4. Elsevier, Amsterdam, New York and Oxford1987: 161-188
        • Vajda F.J.E.
        • Rowe C.C.
        • Berkovic S.F.
        Recent anticonvulsant studies; Promises unfulfilled.
        (Chapter 18)in: Focus on epilepsy. Epilepsy Society of Australia Publication, Melbourne1988: 105-111
        • Vajda F.J.E.
        Gabapentin. Chapter 16..
        in: Eadie M.J. Vajda F.J. Handbook of experimental pharmacology. Antiepileptic drugs pharmacology and therapeutics. vol. 138. Springer-Verlag, Berlin, Heidelberg, New York1999: 425-446
        • Vajda F.J.E.
        Older anticonvulsants continuing in use but with limited advance in knowledge. Chapter 8..
        in: Eadie M.J. Vajda F.J. Handbook of experimental pharmacology. Antiepileptic drugs pharmacology and therapeutics. vol. 138. Springer-Verlag, Berlin, Heidelberg, New York1999: 189-229
        • Dickinson R.G.
        • Eadie M.J.
        • Vajda F.J.E.
        Carbamazepine. Chapter 10..
        in: Eadie M.J. Vajda F.J. Handbook of experimental pharmacology. Antiepileptic drugs pharmacology and therapeutics. vol. 138. Springer-Verlag, Berlin, Heidelberg, New York1999: 276-318
        • Vajda F.J.E.
        Gabapentin: chemistry, clinical pharmacokinetics metabolism and drug interactions. Chapter 30..
        in: Levy R. Meldrum B. Mattson R. Perucca E. Antiepileptic drugs. Lippincott, New York2000: 335-339
        • Mihaly G.
        • Phillips J.
        • Louis W.J.
        • Vajda F.J.E.
        Measurement of carbamazepine and its epoxide in plasma: comparison of assay techniques for measuring carbamazepine.
        J Clin Chem. 1977; 23: 2283-2287
        • Vajda F.J.E.
        • Symington G.
        • Bladin P.H.
        Rectal valproate in intractable status epilepticus.
        Lancet. 1977; i: 359-360
        • Bladin P.F.
        • Vajda F.J.E.
        • Symington G.
        Therapeutic problems related to tonic status epilepticus.
        Clin Exp Neurol. 1977; 14: 203-207
        • Lander C.
        • Donnan G.
        • Bladin P.F.
        • Vajda F.J.E.
        Some aspects of the clinical use of clonazepam in epilepsy.
        Clin Exp Neurol. 1979; 16: 325-332
        • Vajda F.J.E.
        • Donnan G.A.
        • Phillips J.
        • Bladin P.F.
        Human brain, CSF and plasma valproate levels after 72 hours therapy.
        Neurology. 1981; 31: 486-487
        • Vajda F.J.E.
        • Lewis S.J.
        • Harris Q.L.G.
        • Jarrott B.
        • Young N.A.
        Tyrer J.H. Eadie M.J. Tolerance to the anticonvulsant effects of clonazepam and clobazam in the amygdaloid kindled rat. Clinical and experimental neurology. Vol. 22. Adis Press, 1986: 155-164
        • Young N.A.
        • Lewis S.J.
        • Harris Q.L.
        • Jarrott B.
        • Vajda F.J.E.
        Chronic benzodiazepine administration and in vitro binding to cortical synaptosomal fraction.
        Epilepsia. 1988; 30: 458-463
        • Young N.A.
        • Lewis S.J.
        • Harris Q.L.
        • Jarrott B.
        • Vajda F.J.E.
        The development of tolerance to the anticonvulant effects of clonazepam but not sodium valproate in the amygdaloid kindled rat.
        Neuropharmacology. 1987; 26: 1611
        • Salzberg M.
        • Vajda F.J.E.
        Epilepsy, depression and antidepressant drugs.
        J Clin Neurosci. 2001; 8: 209-215
        • Beran R.G.
        • Berkovic S.F.
        • Dunagan F.M.
        • Vajda F.J.E.
        • Danta G.
        • Black A.B.
        • et al.
        A double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
        Epilepsia. 1998; 39: 1329-1333
        • Beghi E.
        • Annegers J.F.
        • Battino D.
        • Montouris G.
        • Morrell M.
        • et al.
        • for the Collaborative Group
        Pregnancy registries in epilepsy.
        Epilepsia. 2000; 2];41: 8-13
        • Tomson T.
        • Battino D.
        • Beausart M.
        • Brodie M.J.
        • Craig J.
        • Lindhout D.
        • et al.
        A European registry of anti-epileptic drugs and pregnancy EURAP: aims, methods and organisation.
        Epilepsia. Oct 2001; 42: 293
        • O'Brien T.J.
        • Meara F.
        • Matthews H.
        • Vajda F.J.E.
        A prospective study of local cutaneous reactions in patients receiving intravenous phenytoin.
        Neurology. 2001; 57: 158-160
        • Frank J.E.
        Neuroprotection and neurodegenerative disease.
        J Clin Neurosci. 2002 Jan; 9: 4-8
        • Solinas C.
        • Vajda F.J.
        Epilepsy and porphyria: new perspectives.
        J Clin Neurosci. May 2004; 11: 356-361
        • Vajda F.J.E.
        • Eadie M.J.
        Maternal valproate dosage and foetal malformations.
        Acta Neurol Scandinavica. 2005; 112: 137-143
        • Vajda F.J.
        • O'Brien T.J.
        • Hitchcock A.
        • Graham J.
        • Cook M.
        • Lander C.M.
        • et al.
        Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of antiepileptic drugs in pregnancy.
        J Clin Neurosci. 2004; 11: 854-858
        • Vajda F.J.E.
        A case for neuroscience trials Australia.
        J Clin Neurosci. 2006; 12: 168-171
        • Beran R.G.
        • Berkovic S.F.
        • Black A.B.
        • Danta G.
        • Hiersemenzel R.
        • Schapel G.J.
        • et al.
        Efficacy and safety of levetiracetam 1000–3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
        Epilepsy Res. 2005; 6;63: 1-9
        • McLean K.J.
        • O'Brien T.J.
        • Cook M.J.
        • Vajda F.J.E.
        The influence of gender on the aggravation of absence seizures by carbamazepine in the low-dose pentylenetetrazol rat model.
        Seizure. 2004; 13: 208-216
        • Vajda F.
        • Lander C.
        • Hitchcock A.
        • Graham J.
        • Solinas C.
        • Eadie M.
        • et al.
        Australian pregnancy registry of women taking antiepileptic drugs.
        Epilepsia. 2004; 45: 1466
        • Eadie M.J.
        • Vajda F.J.E.
        Should valproate be taken during pregnancy?.
        Ther Clin Risk Manag. 2005; 1: 21-26
        • Vajda F.J.E.
        Pharmacotherapy of epilepsy: new armamentarium, new issues.
        J Clin Neurosci. 2007; 6;14: 813-823
        • Vajda F.J.E.
        • O'Brien T.J.
        • Hitchcock A.
        • Graham J.
        • Lander C.
        • Eadie M.
        The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis.
        J Clin Neurosci. 2007; 27;14: 936-942
        • Vajda F.J.E.
        Monitoring antiepileptic drug therapy with serum level measurements.
        Med J Aust. 2007; 187: 581
        • Tomson T.
        • Battino D.
        • French J.
        • Harden C.
        • Holmes L.
        • Morrow J.
        • et al.
        Antiepileptic drug exposure and major congenital malformations: the role of pregnancy registries.
        Epilepsy Behav. 2007; 11: 277-282
        • O'Brien T.J.
        • Hitchcock A.
        • Graham J.
        • Lander C.
        • Eadie M.
        The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies.
        Aust N Z J Obstet Gynaecol. 2007; 47: 468-474
        • Vajda F.J.E.
        • O'Brien T.J.
        • Hitchcock A.
        • Graham J.
        • Lander C.
        • Eadie M.
        The internal control group in a register of antiepileptic drug use in pregnancy.
        J Clin Neurosci. 2008; 26;15: 29-35
        • Vajda F.J.E.
        • O'Brien T.J.
        • Hitchcock A.
        • Graham J.
        • Lander C.
        • Eadie M.
        Seizure control in antiepileptic drug-treated pregnancy.
        Epilepsia. 2008 Jan 21; 49: 172-176
        • Vajda F.J.E.
        Introduction of intravenous formulations of the antiepileptic drugs levetiracetam and valproate to the Australian market.
        J Clin Neurosci. 2009; 4;16: 1709-1710
        • Vajda F.
        • O'Brien T.J.
        Valproic acid use in pregnancy and congenital malformations.
        N Engl J Med. 2010; 363 ([author reply 1771-2]): 1771
        • Vajda F.J.E.
        • Brien T.J.O.
        • Hitchcock A.A.
        • Graham J.
        • Lander C.M.
        • Eadie M.J.
        The teratogenic risk of antiepileptic drug polytherapy.
        Epilepsia. 2010; 8;51: 805-810
        • Tomson T.
        • Battino D.
        • Bonizzoni E.
        • Craig J.
        • Lindhout D.
        • Sabers A.
        • et al.
        Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
        Lancet Neurol. 2011; 5;10: 609-617
        • Vajda F.J.E.
        • Lander C.M.
        • O'Brien T.J.
        • Eadie M.J.
        The rationale for pregnancy registers for women with epilepsy.
        Med J Aust. 2011; 195: 8-9
        • Nadebaum C.
        • Anderson V.
        • Vajda F.
        • Reutens D.
        • Barton S.
        • Wood A.
        The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy.
        J Int Neuropsychol Soc. 2011; 19;17: 133-142
        • Vajda F.J.E.
        • Horgan D.
        • Hollingworth S.
        • Graham J.
        • Hitchcock A.A.
        • Roten A.
        • et al.
        The prescribing of antiepileptic drugs for pregnant Australian women.
        Aust N Z J Obstet Gynaecol. 2012; 12;52: 49-53
        • Nadebaum C.
        • Anderson V.
        • Vajda F.
        • Reutens D.
        • Wood A.
        Neurobehavioral consequences of prenatal antiepileptic drug exposure.
        Dev Neuropsychol. 2012; 37: 1-29
        • Battino D.
        • Tomson T.
        • Bonizzoni E.
        • Craig J.
        • Lindhout D.
        • Sabers A.
        • et al.
        Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
        Epilepsia. 2013; 12;54: 1621-1627
        • Battino D.
        • Tomson T.
        • Bonizzoni E.
        • Craig J.
        • Lindhout D.
        • Sabers A.
        • et al.
        Dose dependence of fetal malformations associated with valproate.
        Neurology. 2013; 2;81: 999-1003
        • Vajda F.J.E.
        • O'Brien T.J.
        • Lander C.M.
        • Graham J.
        • Roten A.
        • Eadie M.J.
        Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
        Epilepsia. 2013; 6;54: 181-186
        • Vajda F.J.E.
        • Dodd S.
        • Horgan D.
        Lamotrigine in epilepsy, pregnancy and psychiatry–a drug for all seasons?.
        J Clin Neurosci. 2013; 1;20: 13-16
        • Vajda F.J.E.
        • Eadie M.J.
        The clinical pharmacology of traditional antiepileptic drugs.
        Epileptic Disord. 2014; 16: 395-408
        • Vajda F.J.E.
        • Lander C.
        • Graham J.
        • Eadie M.
        The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy.
        Epilepsia. 2014; 55: 1229-1234
        • Wood A.G.
        • Chen J.
        • Barton S.
        • Nadebaum C.
        • Anderson V.A.
        • Catroppa C.
        • et al.
        Altered cortical thickness following prenatal sodium valproate exposure.
        Ann Clin Transl Neurol. 2014; 3;1: 497-501
        • Vajda F.J.E.
        Effect of anti-epileptic drug therapy on the unborn child.
        J Clin Neurosci. 2014; 3;21: 716-721
        • Vajda F.
        Epilepsy: effects of exposure to antiepileptic drugs during development.
        Nat Rev. Neurol. Jan 10 2014; 10: 11-12
        • Vajda F.
        Epilepsy: effects of exposure to antiepileptic drugs during development.
        Nat Rev. Neurol. 2014; 10: 11-12
        • Vajda F.
        • Davis S.M.
        • Byrne E.
        Names of infamy, tainted eponyms.
        J Clin Neurosci. 2015; 22: 642-644
        • Tomson T.
        • Battino D.
        • Bonizzoni E.
        • Craig J.
        • Lindhout D.
        • Perucca E.
        • et al.
        Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
        Neurology. 2015; 17;85: 866-872
        • Tomson T.
        • Battino D.
        • Bonizzoni E.
        • Craig J.J.
        • Lindhout D.
        • Perucca E.
        • et al.
        Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP.
        Neurology. 2015; 17;85: 580-588
        • Wood A.G.
        • Nadebaum C.
        • Anderson V.
        • Reutens D.
        • Barton S.
        • Vajda F.
        Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy.
        Epilepsia. 2015; J11;56: 1047-1055
        • Perucca P.
        • Eadie M.
        • Vajda F.J.E.
        Valproate still has a place in women with epilepsy.
        Epilepsia. 2015; 56: 1175-1176
        • Vajda F.
        Saved to remember.
        Monash University Publishing, Melbourne2016 ([ISBN (print): 978-1-925377-08-8. ISBN (e-book): 978-1-925377-])